Cargando…
Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process?
Autores principales: | Yalçın, Nadir, Ak, Sertaç, Demirkan, Kutay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788259/ https://www.ncbi.nlm.nih.gov/pubmed/32620680 http://dx.doi.org/10.1136/ejhpharm-2020-002419 |
Ejemplares similares
-
Benefit versus toxicity risk of digoxin in patients with COVID-19
por: Kelleci Cakir, Burcu, et al.
Publicado: (2022) -
Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA
por: Lippi, Giuseppe, et al.
Publicado: (2022) -
I do not want my baby screened for COVID-19
por: Kelly, Deborah, et al.
Publicado: (2021) -
Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity
por: Komiya, Yasuhiko, et al.
Publicado: (2019) -
British Thoracic Society guideline on pulmonary rehabilitation in adults: does objectivity have a sliding scale?
por: McConnell, Alison K, et al.
Publicado: (2014)